Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunosuppressive Drug Therapy in Membranous Lupus Nephropathy

NCT00001212 is registered in ClinicalTrials.gov with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) as lead sponsor.

NCT NCT00001212
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00001212 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunosuppressive Drug Therapy in Membranous Lupus Nephropathy
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase
Phase 2
Overall status
Completed
Start date
November 30, 1986
Completion date
September 30, 2004
Enrollment
45
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nephrotic syndrome, systemic lupus erythematosus